Per Kogner

Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

Frank Speleman, Rogier Versteeg, Isabelle Janoueix-Lerosey, 2010, Clinical Cancer Research.

Stage-dependent expression of PI3K/Akt‑pathway genes in neuroblastoma.

Per Kogner, Tommy Martinsson, P. Kogner, 2013, International journal of oncology.

Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial.

Günter Schreier, Ruth Ladenstein, Henrik Schroeder, 2017, The Lancet. Oncology.

Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes

Annika Bergman, Staffan Nilsson, Kaisa Thorell, 2009, BMC Medical Genomics.

High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset

Staffan Nilsson, Jonas Abrahamsson, Helena Carén, 2010, Proceedings of the National Academy of Sciences.

Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis.

Christoph Bartenhagen, Matthias Fischer, Tanmoy Mondal, 2018, Cancer cell.

The risk-associated long noncoding RNA NBAT-1 controls neuroblastoma progression by regulating cell proliferation and neuronal differentiation.

Gaurav Kumar Pandey, Leming Shi, Erik Larsson, 2014, Cancer cell.

Risk stratification of high‐risk metastatic neuroblastoma: A report from the HR‐NBL‐1/SIOPEN study

Ruth Ladenstein, Gudrun Schleiermacher, Ulrike Pötschger, 2018, Pediatric blood & cancer.